ASA: Study Describes Non-Operating Room Anesthesia Care

Share this content:
ASA: Study Describes Non-Operating Room Anesthesia Care
ASA: Study Describes Non-Operating Room Anesthesia Care

MONDAY, Oct. 24, 2016 (HealthDay News) -- Patient and case characteristics differ for non-operating room anesthesia (NORA) and operating room (OR) anesthesia, according to a study presented at the annual meeting of the American Society of Anesthesiologists, held from Oct. 22 to 26 in Chicago.

Alexander Nagrebetsky, M.D., from John H. Stroger Hospital of Cook County in Chicago, and colleagues conducted a retrospective analysis of data from the National Anesthesia Clinical Outcomes Registry to summarize NORA patient and case characteristics. The cohort included data reported from 2,439 health care facilities.

The researchers identified 5,929,953 NORA cases and 12,387,574 OR cases. Compared with OR patients, the mean age of NORA patients was 3.5 years higher (P < 0.001). Compared with patients with American Society of Anesthesiologists Physical Status (ASA PS) I to II, patients with ASA PS class III to V were more likely to belong to the NORA group (odds ratio, 1.16; P < 0.001). NORA cases were less likely in small community hospitals than university hospitals (odds ratio, 0.67; P < 0.001). NORA cases were more common outside of normal working hours (odds ratio, 1.33; P < 0.001). The most commonly reported NORA procedure was colonoscopy.

"The growth reflects a shift toward safer, less-invasive procedures and tests that still require anesthesia," a coauthor said in a statement. "It's important that anesthesia for patients with severe health conditions is provided by physician anesthesiologists who have the extensive training and skill to deliver safe care."

Press Release
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell Lymphomas

ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell ...

Second study shows benefit in relapsed or refractory B-cell lymphoma, follicular lymphoma

ASH: AAVD Beats ABVD for Advanced Hodgkin's Lymphoma

ASH: A&#43;AVD Beats ABVD for Advanced Hodgkin's Lymphoma

Lower combined risk of progression, death, or noncomplete response with A+AVD

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia A

ASH: High-Dose Gene Transfer Beneficial in Severe Hemophilia ...

Factor VIII gene transfer tied to sustained normalization of factor VIII activity levels

is free, fast, and customized just for you!

Already a member?

Sign In Now »